SEC Form 4/A · accession 0001140361-18-009199
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jean Jacques Bienaime
Officer — Chief Executive Officer · Director
Period of report
Dec 14, 2017
Accepted (ET)
Feb 20, 2018 · 8:33 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Dec 14, 2017 | G | 600 | $0.00 | D | 182,201 | I | Shares held by Jean-Jacques Bienaime Family Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 14, 2017, the reporting person gifted 600 shares to an educational institution.
- F2On January 2, 2018, the reporting person filed a Form 4 which inadvertently reported the gift as made from the reporting person and not from the reporting person's trust. This amendment corrects such error.